FilingSEC EDGAR8-K
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
· SEC accepted
StageListing Compliance
Filing content
bioAffinity Technologies received notice from Nasdaq that it has regained compliance with listing requirements, and the scheduled hearing was cancelled.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…